PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
13-Jan-2020 Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe Inflazome
13-Jan-2020 Data monitoring committee approves initiation of expansion cohort in colorectal cancer patients Faron Pharmaceuticals
13-Jan-2020 Acquisition of Ashfield Pharmacovigilance Inc., a US pharmacovigilance services provider, from UDG Healthcare for $10 million Ergomed plc
10-Jan-2020 Evotec & Scynexis to lead the workshops for Superbugs & Superdrugs 2020 SMi Group
10-Jan-2020 Toujeo® (insulin glargine) EU licence extended for use in adolescents and children from the age of 6 years with diabetes mellitus Sanofi
10-Jan-2020 ELASMOGEN SECURES £2 M FUNDING Elasmogen Ltd
10-Jan-2020 NBE-Therapeutics Closes USD 22M Series C Financing Round NBE-Therapeutics AG
10-Jan-2020 Glauconix Biosciences Promotes Kimberly Southern to the Position of Chief Executive Officer Glauconix Biosciences Inc
10-Jan-2020 Galen, an Almac Group Company, Announces Completion of Multi-Million Pound POA Pharma Acquisition Almac Group
10-Jan-2020 ProBioGen Inks Next Commercial GlymaxX® License with Roche ProBioGen
10-Jan-2020 BC Platforms Partners with Dante Labs to build Europe’s largest Next Generation Sequencing laboratory for private and public customers BC Platforms
10-Jan-2020 HUMMINGBIRD BIOSCIENCE PUBLISHES PRECLINICAL DATA DEMONSTRATING EFFICACY OF HMBD-001 IN HER3 DRIVEN CANCERS Hummingbird Bioscience
10-Jan-2020 NANOBIOTIX ANNOUNCES PLAN FOR GLOBAL PHASE III HEAD AND NECK CANCER REGISTRATION TRIAL ALONG WITH OVERALL DEVELOPMENT UPDATE NANOBIOTIX
10-Jan-2020 Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio Calibre Scientific
10-Jan-2020 SOTIO Opens Office in Basel, Switzerland, to Accelerate Development of its Pipeline Products SOTIO
09-Jan-2020 Grey Wolf Therapeutics completes £2.5 million Series A2 financing to accelerate development of therapies targeting ERAP2 Grey Wolf Therapeutics
09-Jan-2020 Availability of the Pre-quarterly Results Communication Sanofi
09-Jan-2020 Alderaan Biotechnology raises €18.5M in Series A from Advent France Biotechnology (AFB) and Medicxi Alderaan Biotechnology
09-Jan-2020 Block Commodities strengthens its Scientific Advisory Team (“SAT”) with two key appointments Block Commodities Ltd
09-Jan-2020 Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology Hikma Pharmaceuticals PLC